My research interests focus on understanding the role of sterol/lipid binding proteins in in cholesterol and bile acid homeostasis in normal and disease states; e.g. diabetic nephropathy, NAFLD, and cholestasis.

Dr. Clem’s laboratory focuses on understanding the molecular mechanisms that drive metabolic alterations in cancer.

Our goal is to provide insight into the ethanol-sensitive genes that regulate craniofacial development and lay the groundwork into the mechanistic basis of ethanol teratogenesis.

Dr. Klinge’s research focuses on the molecular mechanisms accounting for acquired endocrine resistance in breast cancer and the role of sex in mitigating the development of non-alcoholic fatty liver disease (NAFLD) in response to environmental pollutants and high fat diet.

I am a geneticist with broad interests in molecular, population, and evolutionary genetics as applied to human and animal model systems.

The Samuelson lab research interest is breast cancer genetics and prevention.

​

My research is focused on the role of redox signaling in oxidative cardiac injury and heart disease.

Dr. Smith's research is focused on utilizing cutting edge genomics technology to parse the complex host-pathogen relationship.

My research regard retinal diseases and the molecular mechanisms of synapse formation in the retina.

The long term goal of my research is to understand the molecular events that underlie the formation and function of one of the synaptic layers, the outer plexiform layer (OPL), in the retina.

The Ellis laboratory is investigating the molecular basis of the bone marrow failure syndrome, Diamond Blackfan anemia (DBA). DBA patients typically have a red blood cell hypoplasia, a heterogeneous collection of developmental abnormalities, and a predisposition to cancer.